Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Tandklinikken CS ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Bankruptcy risk for industry   2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2% 2.2%   Bankruptcy risk   15.6% 12.1% 7.5% 7.4% 7.8% 8.6% 15.8% 15.5%   Credit score (0-100)   13 19 31 32 30 29 12 13   Credit rating   BB BB BB BBB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   171 201 734 1,035 790 656 0.0 0.0   EBITDA   63.6 118 168 116 1.7 -6.0 0.0 0.0   EBIT   49.4 85.8 112 54.1 -60.4 -53.9 0.0 0.0   Pre-tax profit (PTP)   47.9 82.5 104.4 48.2 -60.3 -55.1 0.0 0.0   Net earnings   36.4 63.6 79.3 36.2 -46.5 -62.5 0.0 0.0   Pre-tax profit without non-rec. items   47.9 82.5 104 48.2 -60.3 -55.1 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Tangible assets total   115 149 243 181 119 71.2 0.0 0.0   Shareholders equity total   86.4 150 229 265 219 156 106 106   Interest-bearing liabilities   90.0 91.6 94.0 108 18.0 18.3 0.0 0.0   Balance sheet total (assets)   208 315 423 485 361 268 106 106   Net Debt   45.4 91.5 -37.5 -146 -139 -150 -106 -106     See the entire balance sheet 1000.0 Volume  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   171 201 734 1,035 790 656 0.0 0.0   Gross profit growth   0.0% 17.6% 264.5% 40.9% -23.7% -16.9% -100.0% 0.0%   Employees   0 0 0 0 0 2 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   208 315 423 485 361 268 106 106   Balance sheet change%   0.0% 51.4% 34.3% 14.5% -25.5% -25.7% -60.3% 0.0%   Added value   63.6 117.9 167.5 116.2 1.7 -6.0 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   100 2 39 -124 -124 -96 -71 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   28.9% 42.6% 15.3% 5.2% -7.6% -8.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   23.7% 32.8% 30.4% 11.9% -14.3% -17.1% 0.0% 0.0%   ROI %   27.4% 40.1% 38.7% 15.2% -19.6% -26.1% 0.0% 0.0%   ROE %   42.1% 53.8% 41.8% 14.6% -19.2% -33.3% 0.0% 0.0%   1000.0 Solidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Equity ratio %   41.5% 47.6% 54.2% 54.8% 60.7% 58.3% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   71.3% 77.6% -22.4% -125.6% -7,932.3% 2,486.6% 0.0% 0.0%   Gearing %   104.2% 61.0% 41.0% 40.7% 8.2% 11.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   3.3% 3.6% 8.4% 5.8% 0.0% 8.2% 0.0% 0.0%   1000.0 Liquidity  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Quick Ratio   0.5 0.8 0.7 1.2 1.3 1.6 0.0 0.0   Current Ratio   0.5 0.8 0.7 1.2 1.3 1.6 0.0 0.0   Cash and cash equivalent   44.6 0.0 131.5 254.0 156.7 167.9 0.0 0.0   1000.0 Capital use efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -55.7 -25.3 -53.8 41.1 44.4 64.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024 2024/12 2025e N/A 2026e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 -3 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 -3 0 0   EBIT / employee   0 0 0 0 0 -27 0 0   Net earnings / employee   0 0 0 0 0 -31 0 0